RPG LIFE SCIENCES LTD (RPGLIFE) financials

RPG LIFE SCIENCES LTD (RPGLIFE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2007, RPG Life Sciences Ltd manufactures and markets Formulations (Finished Dosage Forms) and Active Pharma Ingredients[1]

Market Cap: ₹4,844Cr.
Current Price: ₹2,929
Stock P/E: 41.5
ROE: 19.3%
ROCE: 25.7%
Book Value: ₹366
Dividend Yield: 0.82%
52W High / Low: ₹3,130/1,731

In Jun 2026, RPG LIFE SCIENCES LTD (RPGLIFE) reported sales ₹196 Cr and net profit ₹31 Cr.

Annual TTM: sales ₹734 Cr, net profit ₹119 Cr.

Shareholding: Promoters 72.95% (Sep 2026), FIIs 0.87% (Sep 2026), DIIs 9.93% (Sep 2026), Public 16.24% (Sep 2026), No. of Shareholders 24,330% (Sep 2026).

RPGLIFE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	172	173	143	169	182	180	177	196
Expenses	126	124	118	133	143	140	144	152
Operating Profit	46	49	25	35	39	40	33	44
OPM %	27%	28%	18%	21%	21%	22%	19%	22%
Other Income	-25	3	115	5	16	-5	13	4
Interest	0	0	0	0	0	0	0	1
Depreciation	5	5	5	5	5	5	6	6
Profit before tax	15	47	135	35	49	29	40	41
Tax %	72%	26%	13%	26%	25%	24%	26%	26%
Net Profit	4	35	117	26	37	22	30	31
EPS in Rs	2.54	21.12	70.95	15.90	22.28	13.38	18.08	18.48
Raw PDF	—	—	—	—	—	—	—	—

RPGLIFE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	376	389	440	513	582	653	708	734
Expenses	315	318	353	408	453	493	560	579
Operating Profit	60	71	87	104	129	161	148	155
OPM %	16%	18%	20%	20%	22%	25%	21%	21%
Other Income	-5	1	3	4	7	95	29	28
Interest	3	2	1	1	1	2	2	1
Depreciation	16	16	16	16	17	21	21	22
Profit before tax	36	54	73	92	118	233	154	160
Tax %	20%	25%	30%	26%	26%	21%	25%	—
Net Profit	29	40	51	68	88	183	115	119
EPS in Rs	17.54	24.19	31.13	40.90	53.00	110.79	69.64	72.22
Dividend Payout %	23%	30%	31%	29%	30%	22%	34%	—

RPGLIFE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	13	13	13	13	13	13	13	13
Reserves	147	163	203	243	294	362	517	592
Borrowings	36	12	2	1	0	-0	-0	20
Other Liabilities	54	78	85	88	112	138	127	168
Total Liabilities	251	267	303	345	419	513	658	793
Fixed Assets	128	123	113	104	124	114	172	197
CWIP	17	10	12	31	25	96	16	23
Investments	-0	-0	-0	-0	58	91	127	120
Other Assets	106	134	178	210	211	212	343	454
Total Assets	251	267	303	345	419	513	658	793

RPGLIFE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	46	50	58	65	91	94	78	56
Cash from Investing Activity	-19	-11	-8	-35	-106	-79	-42	51
Cash from Financing Activity	-26	-39	-10	-14	-17	-20	-27	-21
Net Cash Flow	0	0	40	17	-32	-5	9	87
Free Cash Flow	26	39	50	41	58	25	151	-9
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	144%	94%	94%	96%	111%	96%	81%	63%

RPGLIFE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	72.95%	72.95%	72.95%	72.95%	72.95%	72.95%	72.95%	72.95%
FIIs	1.30%	1.46%	1.35%	1.11%	1.00%	0.87%	0.95%	0.87%
DIIs	6.06%	6.14%	6.49%	6.70%	7.04%	7.45%	8.68%	9.93%
Public	19.70%	19.46%	19.22%	19.23%	19.01%	18.72%	17.42%	16.24%
No. of Shareholders	24,891	24,867	25,832	26,657	25,905	25,282	23,886	24,330

RPGLIFE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	43	62	54	27	27	31	48	60
Inventory Days	136	133	162	214	203	200	159	179
Days Payable	83	127	132	117	138	140	135	141
Cash Conversion Cycle	96	68	84	124	91	90	72	99
Working Capital Days	20	41	52	47	33	25	45	64
ROCE %	10%	23%	27%	31%	33%	35%	33%	26%

RPGLIFEUpdated 16 Oct 2026, 11:59

Rpg Life Sciences Ltd

RPGLIFEUpdated 16 Oct 2026, 11:59

Market Cap

₹4,844Cr.

Current Price

₹2,929

High / Low

₹3,130/1,731

Stock P/E

41.5

ROE19.3%

ROCE25.7%

Book Value₹366

Face Value₹8.00

Dividend Yield0.82%

About

Incorporated in 2007, RPG Life Sciences Ltd manufactures and markets Formulations (Finished Dosage Forms) and Active Pharma Ingredients[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	148	0	116	2	4	30	26	22	13.36
Sep 2023	154	0	116	2	4	35	26	26	15.64
Dec 2023	154	0	116	2	4	36	26	26	16
Mar 2024	127	0	106	2	4	18	25	13	8.01
Jun 2024	165	0	126	2	5	36	26	27	16.18
Sep 2024	172	0	126	-25	5	15	72	4	2.54
Dec 2024	173	0	124	3	5	47	26	35	21.12
Mar 2025	143	0	118	115	5	135	13	117	70.95
Jun 2025	169	0	133	5	5	35	26	26	15.9
Sep 2025	182	0	143	16	5	49	25	37	22.28
Dec 2025	180	0	140	-5	5	29	24	22	13.38
Mar 2026	177	0	144	13	6	40	26	30	18.08
Jun 2026	196	1	152	4	6	41	26	31	18.48

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	242	3	228	1	11	1	0	1	0.6
Mar 2016	279	2	256	1	10	12	0	12	7.03
Mar 2017	294	4	274	18	11	23	10	21	12.7
Mar 2018	344	5	306	1	14	20	34	13	8.13
Mar 2019	330	5	296	1	15	15	28	11	6.54
Mar 2020	376	3	315	-5	16	36	20	29	17.54
Mar 2021	389	2	318	1	16	54	25	40	24.19
Mar 2022	440	1	353	3	16	73	30	51	31.13
Mar 2023	513	1	408	4	16	92	26	68	40.9
Mar 2024	582	1	453	7	17	118	26	88	53
Mar 2025	653	2	493	95	21	233	21	183	110.79
Mar 2026	708	2	560	29	21	154	25	115	69.64
TTM	734	1	579	28	22	160	—	119	72.22

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	72.95%
FIIs	0.87%
DIIs	9.93%
Public	16.24%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	72.82%	0.56%	1.77%	24.85%
Mar 2024	72.82%	0.9%	2.16%	24.12%
Jun 2024	72.82%	1.15%	2.61%	23.44%
Sep 2024	72.82%	1.35%	5.45%	20.4%
Dec 2024	72.95%	1.3%	6.06%	19.7%
Mar 2025	72.95%	1.46%	6.14%	19.46%
Jun 2025	72.95%	1.35%	6.49%	19.22%
Sep 2025	72.95%	1.11%	6.7%	19.23%
Dec 2025	72.95%	1%	7.04%	19.01%
Mar 2026	72.95%	0.87%	7.45%	18.72%
Jun 2026	72.95%	0.95%	8.68%	17.42%
Sep 2026	72.95%	0.87%	9.93%	16.24%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	13	112	33	39	197	105	1	0	92	197
Mar 2016	13	120	23	49	205	109	2	0	94	205
Mar 2017	13	134	45	55	247	137	2	0	108	247
Mar 2018	13	142	54	82	291	131	9	0	152	291
Mar 2019	13	147	36	54	251	128	17	0	106	251
Mar 2020	13	163	12	78	267	123	10	0	134	267
Mar 2021	13	203	2	85	303	113	12	0	178	303
Mar 2022	13	243	1	88	345	104	31	0	210	345
Mar 2023	13	294	0	112	419	124	25	58	211	419
Mar 2024	13	362	0	138	513	114	96	91	212	513
Mar 2025	13	517	0	127	658	172	16	127	343	658
Mar 2026	13	592	20	168	793	197	23	120	454	793

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-2	-10	12	0
Mar 2016	33	-15	-18	0
Mar 2017	7	-30	23	1
Mar 2018	15	-16	0	-1
Mar 2019	46	-19	-26	0
Mar 2020	50	-11	-39	0
Mar 2021	58	-8	-10	40
Mar 2022	65	-35	-14	17
Mar 2023	91	-106	-17	-32
Mar 2024	94	-79	-20	-5
Mar 2025	78	-42	-27	9
Mar 2026	56	51	-21	87

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	61	48	49	72	43	62	54	27	27	31	48	60
Inventory Days	149	156	163	171	136	133	162	214	203	200	159	179
Days Payable	109	135	102	165	83	127	132	117	138	140	135	141
Cash Conversion Cycle	101	70	110	78	96	68	84	124	91	90	72	99
Working Capital Days	27	26	20	22	20	41	52	47	33	25	45	64
ROCE %	2%	9%	10%	13%	10%	23%	27%	31%	33%	35%	33%	26%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of RPG LIFE SCIENCES LTD (RPGLIFE)?

The reported market capitalisation for RPG LIFE SCIENCES LTD (RPGLIFE) is ₹4,844Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of RPGLIFE?

The current price shown for RPG LIFE SCIENCES LTD (RPGLIFE) on Fincrux is ₹2,929 with a 52-week high/low of ₹3,130/1,731.

What is the P/E ratio of RPG LIFE SCIENCES LTD (RPGLIFE)?

The stock P/E for RPG LIFE SCIENCES LTD (RPGLIFE) is 41.5 on Fincrux, with ROE at 19.3% and ROCE at 25.7%.

What were RPGLIFE latest quarterly results?

For Jun 2026, RPG LIFE SCIENCES LTD (RPGLIFE) reported sales ₹196 Cr and net profit ₹31 Cr (figures in ₹ crore unless noted).

What are RPGLIFE annual sales and net profit?

For TTM, RPG LIFE SCIENCES LTD (RPGLIFE) shows sales of ₹734 Cr and net profit of ₹119 Cr on the Fincrux profit & loss statement.

Who owns RPG LIFE SCIENCES LTD (RPGLIFE)?

Latest shareholding for RPG LIFE SCIENCES LTD (RPGLIFE) on Fincrux: Promoters 72.95% (Sep 2026), FIIs 0.87% (Sep 2026), DIIs 9.93% (Sep 2026), Public 16.24% (Sep 2026), No. of Shareholders 24,330% (Sep 2026).

Where can I find RPG LIFE SCIENCES LTD (RPGLIFE) financials?

RPG LIFE SCIENCES LTD (RPGLIFE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show RPGLIFE balance sheet and cash flow?

Yes. The RPG LIFE SCIENCES LTD (RPGLIFE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 16 October 2026 at 11:59